The Queen Mary University of London Centre for Predictive in vitro Models (CPM) is a world-leading research and innovation hub dedicated to advancing the use of complex in vitro models to predict human disease and therapeutic responses. The Centre brings together over 70 academic staff with multidisciplinary expertise in cell biology, tissue engineering, pharmacology, and computational modelling, working collaboratively to develop and apply cutting-edge in vitro models that are capable of simulating human biology in ways that traditional models cannot.
At its core, CPM aims to facilitate the implementation of predictive in vitro models across a broad range of disciplines, driving forward the highest quality discovery science while accelerating the delivery of safe and effective therapeutics. The Centre's vision is to provide transformative solutions that bridge the gap between laboratory-based research and real-world clinical applications. This is achieved through the development of sophisticated, high-fidelity in vitro models that can better mimic human physiology, improve drug development processes, and reduce reliance on animal testing.
The CPM's expertise spans research, training, and translation, equipping the next generation of scientists with the skills needed to harness these innovative models. The Centre actively engages in public engagement and policy shaping, working with regulators, policymakers, and the public to influence the future of biomedical science and promote the adoption of in vitro technologies in research and healthcare.
The Centre’s collaborative approach fosters strong partnerships with industry leaders, healthcare providers, and academic institutions, positioning CPM at the forefront of in vitro model development. By combining interdisciplinary expertise with cutting-edge technology, the Centre is accelerating the transition of predictive in vitro models from the laboratory to practical, real-world applications.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Engineering Building, Queen Mary University Of London,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cpm.qmul.ac.uk/
- Keywords
- microphysiological systems, organoid, organ-on-a-chip, in vitro models, non-animal methods, new approach methodologies, tissue engineering, biotechnology, biomedical engineering, biomechanics, mechanobiology, drug discovery, research, traning, clinical translation.
- HQ
- London, London
Queen Mary's Centre For Predictive In Vitro Models Questions
Queen Mary'S Centre For Predictive In Vitro Models's website is https://www.cpm.qmul.ac.uk/
Queen Mary'S Centre For Predictive In Vitro Models's LinkedIn profile is https://uk.linkedin.com/company/qmul-centre-for-predictive-in-vitro-models
Queen Mary'S Centre For Predictive In Vitro Models has
1 employees.
View email and phone details for 1
employees at Queen Mary'S Centre For Predictive In Vitro Models.
Queen Mary'S Centre For Predictive In Vitro Models's industry is
Biotechnology Research
Queen Mary'S Centre For Predictive In Vitro Models's top competitors are
Bristol Myers Squibb,
International Mps Society (Impss),
Worc.community: The Only Social Media Network Just For Organoid 🧫organ-On-Chip 🧬 & Nam Researchers,
Euroocs,
Hub Organoids,
Cn Bio,
Epsrc,
Nus Department Of Biomedical Engineering,
Organoid@kul,
Emulate, Inc..
Queen Mary'S Centre For Predictive In Vitro Models's categories are Biotechnology Research
Queen Mary'S Centre For Predictive In Vitro Models's founding year is 2020
